Market Currents
Salix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its...
-
Wednesday, December 14, 2011, 12:19 PM ETSalix Pharmaceuticals (SLXP +0.2%) says it's submitted a New Drug Application to the FDA for its HIV-induced diarrhea drug Crofelemer. The agency has 60 days to review the application and decide whether it will enter its review process. The drug developer is also researching alternative possible uses for the drug, including the treatment of irritable bowel syndrome.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
